At the news
? BEARISHIMPACT 8/10 8-K filed Jul 16, 2026 at 16:52 ET
Cycurion received a Nasdaq delisting determination letter because its common stock closing bid price remained below $1.00 for 31 consecutive business days. The company is ineligible for the standard 180-day cure period due to a prior reverse stock split, and trading is set to be suspended on July 21, 2026, unless a hearing stay is granted. The company plans to appeal, but delisting risk is high and would severely impair liquidity and institutional ownership for this $5M market cap issuer.
- Nasdaq determined to delist CYCU common stock for failing to meet the $1.00 minimum bid price requirement under Listing Rule 5550(a)(1).
- The closing bid price was below $1.00 for 31 consecutive business days from May 26, 2026 through July 9, 2026.
- Cycurion is not eligible for the customary 180-day compliance period because it effected a 1-for-30 reverse stock split on October 27, 2025.
- Absent a timely hearing request, trading in CYCU securities is expected to be suspended at the opening of business on July 21, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access